First Postpartum Depression Pill Now Available in the U.S.

The first oral pill approved in the U.S. to treat postpartum depression is now available by prescription, according to the drugmakers. The US Food and Drug Administration approved the therapy, called Zurzuvae, in August. The product, which is now at specialty pharmacies, can be shipped directly to patients, Biogen and Sage Therapeutics Inc. said in an announcement last Thursday.

However, the medication will cost $15,900 per course before insurance, raising some concerns about how many people will be able to access it. Read more from CNN here.